Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 7/2010

Open Access 01-07-2010 | Original Paper

Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation

Authors: Mao Xiu Zhang, Xu Zhao, Zhi Gang Wang, Wei Ming Zhao, Yun Shan Wang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 7/2010

Login to get access

Abstract

Purpose

Janus tyrosine kinases (JAKs) and signal transducer and activator of transcription factors (STATs), especially STAT3, are constitutively activated in human cancers. The function of STAT3 in the pathogenesis of meningioma remains unknown. In this study, we investigated the role of JAK1/STAT3 regulating vascular endothelial growth factor (VEGF) expression in the occurrence and progression of human meningioma.

Methods

We detected the expression of JAK1, p-JAK1, STAT3, p-STAT3, and VEGF in human meningioma and normal dura tissues by RT–PCR, Western blot analysis, and immunohistochemistry.

Results

JAK1, p-JAK1, STAT3, p-STAT3, and VEGF showed high expression in grade I and grade II meningioma. The level of STAT3 activation was associated with VEGF expression; all meningioma tumors that expressed p-STAT3 also expressed VEGF. Both frequency of positivity and expression were enhanced with increasing tumor grade; high frequencies and levels were found in grade II tumors, with no expression detected in normal dura tissues (P < 0.05).

Conclusions

VEGF is directly regulated by constitutive STAT3 activity and associated with meningioma differentiation. STAT3 has an important role in the occurrence and development of human meningioma by regulating VEGF expression.
Literature
go back to reference Akira S (1999) Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17:138–146CrossRefPubMed Akira S (1999) Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17:138–146CrossRefPubMed
go back to reference Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153–159CrossRefPubMed Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 91:153–159CrossRefPubMed
go back to reference Bharti AC, Donato N, Aggarwal BB (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171:3863–3871PubMed Bharti AC, Donato N, Aggarwal BB (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171:3863–3871PubMed
go back to reference Carlesso N, Frank DA, Griffin JD (1996) Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811–820CrossRefPubMed Carlesso N, Frank DA, Griffin JD (1996) Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J Exp Med 183:811–820CrossRefPubMed
go back to reference Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS, Jove R (1999) Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105–115CrossRefPubMed Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS, Jove R (1999) Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105–115CrossRefPubMed
go back to reference Cattaneo E, Magrassi L, De-Fraja C, Conti L, Di Gennaro I, Butti G, Govoni S (1998) Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res 18:2381–2387PubMed Cattaneo E, Magrassi L, De-Fraja C, Conti L, Di Gennaro I, Butti G, Govoni S (1998) Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res 18:2381–2387PubMed
go back to reference Chen SH, Murphy DA, Lassoued W, Thurston G, Feldman MD, Lee WM (2008) Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther 7:1994–2003PubMed Chen SH, Murphy DA, Lassoued W, Thurston G, Feldman MD, Lee WM (2008) Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther 7:1994–2003PubMed
go back to reference Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, Lacout C, Guilhot F, Vainchenker W, Turhan AG (2006) BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol 134:171–179CrossRefPubMed Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, Lacout C, Guilhot F, Vainchenker W, Turhan AG (2006) BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol 134:171–179CrossRefPubMed
go back to reference De-Fraja C, Conti L, Govoni S, Battaini F, Cattaneo E (2000) STAT signalling in the mature and aging brain. Int J Dev Neurosci 18:439–446CrossRefPubMed De-Fraja C, Conti L, Govoni S, Battaini F, Cattaneo E (2000) STAT signalling in the mature and aging brain. Int J Dev Neurosci 18:439–446CrossRefPubMed
go back to reference Gautron L, De Smedt-Peyrusse V, Layé S (2006) Characterization of STAT3-expressing cells in the postnatal rat brain. Brain Res 1098:26–32CrossRefPubMed Gautron L, De Smedt-Peyrusse V, Layé S (2006) Characterization of STAT3-expressing cells in the postnatal rat brain. Brain Res 1098:26–32CrossRefPubMed
go back to reference Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark GR (1995) A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J 14:1421–1429PubMed Guschin D, Rogers N, Briscoe J, Witthuhn B, Watling D, Horn F, Pellegrini S, Yasukawa K, Heinrich P, Stark GR (1995) A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J 14:1421–1429PubMed
go back to reference Haridas V, Nishimura G, Xu ZX, Connolly F, Hanausek M, Walaszek Z, Zoltaszek R, Gutterman JU (2009) Avicin D: a protein reactive plant isoprenoid dephosphorylates STAT3 by regulating both kinase and phosphatase activities. PLoS One 4:e5578CrossRefPubMed Haridas V, Nishimura G, Xu ZX, Connolly F, Hanausek M, Walaszek Z, Zoltaszek R, Gutterman JU (2009) Avicin D: a protein reactive plant isoprenoid dephosphorylates STAT3 by regulating both kinase and phosphatase activities. PLoS One 4:e5578CrossRefPubMed
go back to reference Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R (2005) Expression of VEGF and its receptors in different brain tumors. Neurol Res 27:371–377CrossRefPubMed Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R (2005) Expression of VEGF and its receptors in different brain tumors. Neurol Res 27:371–377CrossRefPubMed
go back to reference Kim ES, Hong SY, Lee HK, Kim SW, An MJ, Kim TI, Lee KR, Kim WH, Cheon JH (2008) Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Oncol Rep 20:1321–1327PubMed Kim ES, Hong SY, Lee HK, Kim SW, An MJ, Kim TI, Lee KR, Kim WH, Cheon JH (2008) Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Oncol Rep 20:1321–1327PubMed
go back to reference Knoops L, Hornakova T, Royer Y, Constantinescu SN, Renauld JC (2008) JAK kinases overexpression promotes in vitro cell transformation. Oncogene 27:1511–1519CrossRefPubMed Knoops L, Hornakova T, Royer Y, Constantinescu SN, Renauld JC (2008) JAK kinases overexpression promotes in vitro cell transformation. Oncogene 27:1511–1519CrossRefPubMed
go back to reference Lee CK, Bluyssen HA, Levy DE (1997) Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. J Biol Chem 272:21872–21877CrossRefPubMed Lee CK, Bluyssen HA, Levy DE (1997) Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. J Biol Chem 272:21872–21877CrossRefPubMed
go back to reference Loeffler S, Fayard B, Weis J, Weissenberger J (2005) Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115:202–213CrossRefPubMed Loeffler S, Fayard B, Weis J, Weissenberger J (2005) Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115:202–213CrossRefPubMed
go back to reference Magrassi L, De-Fraja C, Conti L, Butti G, Infuso L, Govoni S, Cattaneo E (1999) Expression of the JAK and STAT superfamilies in human meningiomas. J Neurosurg 91:440–446CrossRefPubMed Magrassi L, De-Fraja C, Conti L, Butti G, Infuso L, Govoni S, Cattaneo E (1999) Expression of the JAK and STAT superfamilies in human meningiomas. J Neurosurg 91:440–446CrossRefPubMed
go back to reference Mahboubi K, Li F, Plescia J, Kirkiles-Smith NC, Mesri M, Du Y, Carroll JM, Elias JA, Altieri DC, Pober JS (2001) Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest 81:327–334PubMed Mahboubi K, Li F, Plescia J, Kirkiles-Smith NC, Mesri M, Du Y, Carroll JM, Elias JA, Altieri DC, Pober JS (2001) Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab Invest 81:327–334PubMed
go back to reference Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H (2002) Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000–2008CrossRefPubMed Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H (2002) Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000–2008CrossRefPubMed
go back to reference Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y, Sasaki T (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 2:1411–1416PubMed Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y, Sasaki T (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 2:1411–1416PubMed
go back to reference Preusser M, Birner P, Ambros IM, Ambros PF, Budka H, Harris AL, Hainfellner JA (2005) DEC1 expression in 1p-aberrant oligodendroglial neoplasms. Histol Histopathol 20:1173–1176PubMed Preusser M, Birner P, Ambros IM, Ambros PF, Budka H, Harris AL, Hainfellner JA (2005) DEC1 expression in 1p-aberrant oligodendroglial neoplasms. Histol Histopathol 20:1173–1176PubMed
go back to reference Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM Jr, Schreiber RD (1998) Disruption of the JAK1 gene demonstrates obligatory and nonredundant roles of the JAKs in cytokine-induced biologic responses. Cell 93:373–383CrossRefPubMed Rodig SJ, Meraz MA, White JM, Lampe PA, Riley JK, Arthur CD, King KL, Sheehan KC, Yin L, Pennica D, Johnson EM Jr, Schreiber RD (1998) Disruption of the JAK1 gene demonstrates obligatory and nonredundant roles of the JAKs in cytokine-induced biologic responses. Cell 93:373–383CrossRefPubMed
go back to reference Rubin Grandis J, Zeng Q, Drenning SD (2000) Epidermal growth factor receptor-mediated STAT3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 110:868–874CrossRefPubMed Rubin Grandis J, Zeng Q, Drenning SD (2000) Epidermal growth factor receptor-mediated STAT3 signaling blocks apoptosis in head and neck cancer. Laryngoscope 110:868–874CrossRefPubMed
go back to reference Schaefer LK, Ren Z, Fuller GN, Schaefer TS (2002) Constitutive activation of STAT3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21:2058–2065CrossRefPubMed Schaefer LK, Ren Z, Fuller GN, Schaefer TS (2002) Constitutive activation of STAT3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21:2058–2065CrossRefPubMed
go back to reference Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S (1997) Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94:3801–3804CrossRefPubMed Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S (1997) Targeted disruption of the mouse STAT3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 94:3801–3804CrossRefPubMed
go back to reference Tam L, McGlynn LM, Traynor P, Mukherjee R, Bartlett JM, Edwards J (2007) Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. Br J Cancer 97:378–383CrossRefPubMed Tam L, McGlynn LM, Traynor P, Mukherjee R, Bartlett JM, Edwards J (2007) Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer. Br J Cancer 97:378–383CrossRefPubMed
go back to reference Tian SS, Lamb P, Seidel HM, Stein RB, Rosen J (1994) Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84:1760–1764PubMed Tian SS, Lamb P, Seidel HM, Stein RB, Rosen J (1994) Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84:1760–1764PubMed
go back to reference Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 27:6613–6626CrossRef Turkson J, Jove R (2000) STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 27:6613–6626CrossRef
go back to reference Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN (2004) Analysis of the activation status of Akt, NFkappaB, and STAT3 in human diffuse gliomas. Lab Invest 84:941–951CrossRefPubMed Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN (2004) Analysis of the activation status of Akt, NFkappaB, and STAT3 in human diffuse gliomas. Lab Invest 84:941–951CrossRefPubMed
go back to reference Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J (1996) Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809–816PubMed Weber-Nordt RM, Egen C, Wehinger J, Ludwig W, Gouilleux-Gruart V, Mertelsmann R, Finke J (1996) Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88:809–816PubMed
go back to reference Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K (2003) STAT3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22:319–329CrossRefPubMed Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K (2003) STAT3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22:319–329CrossRefPubMed
go back to reference Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R (2000) Activation of STAT3 in v-Src-transformed fibroblasts requires cooperation of JAK1 kinase activity. J Biol Chem 275:24935–24944CrossRefPubMed Zhang Y, Turkson J, Carter-Su C, Smithgall T, Levitzki A, Kraker A, Krolewski JJ, Medveczky P, Jove R (2000) Activation of STAT3 in v-Src-transformed fibroblasts requires cooperation of JAK1 kinase activity. J Biol Chem 275:24935–24944CrossRefPubMed
Metadata
Title
Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation
Authors
Mao Xiu Zhang
Xu Zhao
Zhi Gang Wang
Wei Ming Zhao
Yun Shan Wang
Publication date
01-07-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 7/2010
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0743-9

Other articles of this Issue 7/2010

Journal of Cancer Research and Clinical Oncology 7/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.